Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Gleam Care, Inc. is a San Francisco-based YC S23 startup building a browser-based, human-in-the-loop data-entry assistant for clinical research sites. Its software copies source data into EDC CRFs faster, with traceability and built-in QC, and sells directly to research sites rather than sponsors.
Primary product
Browser-based clinical research site data-entry assistant that moves source data into EDC CRFs with traceability and QC review
Founded
2023
Headquarters
San Francisco, California, United States
Team size
1-10
Industry
Software Development
Sub-industry
Clinical research site data-entry software
Offices
0 jobs at Gleam
Check back later for new openings
Business model
Stage
Pre-Seed
Total raised
$500K
Latest round
Pre-Seed · Apr 2023
Latest amount
$500K
Apr 2023 · Focal
The company emphasizes a site-first, human-in-the-loop culture: 'felt, not seen', 'verify, then trust', and a product philosophy that explicitly says it optimizes for joy.
Pricing
Direct-to-site, request-a-demo sales model; public pricing is not posted.
Differentiators
Technology
Customers
Competitors
Gleam blog · Jun 2026
Explains Gleam's position on AI-assisted data entry for research sites, arguing that human-reviewed, traceable AI does not change site accountability and is compatible with FDA expectations when the system is fit for purpose and users remain responsible.
Gleam blog · Jun 2026
Podcast-style article featuring Oliver Keh discussing AI at research sites, FDA perceptions, eSource, and the persistent pain of manual data entry.
Gleam blog · Apr 2026
Michael Felix discusses Gleam's culture and product philosophy, including 'optimizing for joy', 'felt, not seen', and 'verify, then trust'.
Gleam blog · Mar 2026
Sets out Gleam's trust and transparency principles for clinical research data entry, emphasizing human-in-the-loop review and source traceability.